Supplements and Featured Publications

Emerging Treatments and Clinical Challenges in Myelodysplastic Syndromes: ASCO 2021 and EHA 2021 Updates
Volume: 1
Issue: 1
This publication features research that was presented in myelodysplastic syndromes from the 2021 ASCO Annual Meeting and 2021 EHA Congress, including expert perspectives on how the data have clinical implications.
Sponsored by Takeda Oncology/Content Developed Independently by OncLive

ASCO 2021: Updates in Myeloproliferative Neoplasms
Volume: 1
Issue: 1
This publication covers a multitude of presentations in myeloproliferative neoplasms that were presented and discussed during the 2021 ASCO Annual Meeting.

ASCO 2021: Updates in Genitourinary Cancers
Volume: 1
Issue: 1
This publication provides coverage of data in genitourinary cancers that were presented at the 2021 ASCO Annual Meeting.

My Treatment Approach: Lung Cancer Practice Patterns
Volume: 1
Issue: 1

The Evolving Role of Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Volume: 1
Issue: 1

2021 EBMT Annual Meeting
Volume: 1
Issue: 1
Coverage of the 2021 EBMT Annual Meeting, held virtually March 14-17, 2021.

Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer
Volume: 01
Issue: 01

2021 Genitourinary Cancers Symposium
Volume: 02
Issue: 1

2021 Gastrointestinal Cancers Symposium
Volume: 1
Issue: 1

Updates in NRG1+ Tumors

My Treatment Approach: BRAF+ Melanoma
Volume: 1
Issue: 1

ASH 2020: CAR T-Cell Therapy Updates
Volume: 1
Issue: 1

Frontline Immunotherapy Updates in Advanced NSCLC
Volume: 1
Issue: 1

Year in Review: HER2+ Updates in Oncology
Volume: 1
Issue: 1

Updates in Relapsed/Refractory AML
Volume: 1
Issue: 1

Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2
Volume: 1
Issue: 2

Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1
Volume: 1
Issue: 1

Updates and Advances in Basal Cell Carcinoma
Volume: 2
Issue: 2

SABCS 2020: Reflections in HER2+ Breast Cancer
Volume: 1
Issue: 1

Current and Emerging Trends in Chronic Myeloid Leukemia
Volume: 1
Issue: 1

My Treatment Approach: Locally Advanced Lung Cancer
Volume: 1
Issue: 1

Utilizing Tumor Metabolism in Solid Malignancies
Volume: 1
Issue: 1

Updates in ESR1-Mutant Breast Cancer
Volume: 1
Issue: 1

My Treatment Approach: Multiple Myeloma
Volume: 1
Issue: 1

My Treatment Approach: Chronic Lymphocytic Leukemia
Volume: 1
Issue: 1

Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Volume: 1
Issue: 1

Role of Trop-2 as an Actionable Biomarker in Solid Tumors
Volume: 1
Issue: 1

The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer
Volume: 1
Issue: 1

ESMO 2020 Congress: Focus in Genitourinary Cancers
Volume: 1
Issue: 1

Updates and New Targets in NSCLC: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
3
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5

